The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
“The Times They Are A Changin:” Home Diagnosis of Sleep Apnea Has Arrived
Abstract
Dr. Atwood has indicated no financial conflicts of interest. As anyone in the clinical practice of sleep medicine is keenly aware, the traditional approach to the diagnosis of and initiation of continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) is undergoing a sea change. Since 2008, and the Centers for Medicare and Medicaid Services (CMS) approval of home sleep testing for the diagnosis of OSA when CPAP is to be prescribed, the door to the non-laboratory diagnosis of sleep apnea has been opening ever more steadily.1 The concern many sleep medicine practitioners have is that, while there may be some advantages to home testing for sleep apnea in terms of a more realistic “ecology” for the patient, clinical outcomes will not be as good as they are with sleep laboratory and PSG diagnosis and CPAP titration To address the need for better evidence supporting the use of home OSA testing, the evidence base for home sleep apnea testing has been also been growing. Since 2007 we have seen clinical trials2-5 published that have begun to consistently demonstrate that clinical outcomes relevant to OSA patients are essentially the same regardless of whether the diagnosis and initiation of positive airway pressure therapy is performed in the home setting or in the laboratory setting. In this edition of SLEEP, Rosen and colleagues6 have published the latest contribution to this literature, the HomePAP study. The HomePAP study investigators performed a multisite, randomized, open label, parallel group clinical trial, which compared a home-based unattended sleep apnea monitor for the diagnosis of OSA, and then followed that with a trial of au-totitrating CPAP for patients who were positive for OSA on the diagnostic study with a sleep laboratory-based diagnostic poly-somnogram followed by a CPAP titration performed in a sleep laboratory. The study population was middle-aged (average age 46 ± 12 years), 60% male, 64% Caucasian, and obese (average BMI 37.2 ± 8.7) and lived in proximity to 1 of 7 academic sleep medicine centers where they were referred for evaluation. The population was prescreened significantly to select for patients who were excessively sleepy, as determined by an Ep-worth Sleepiness Scale value of 12 or higher,7 and likely to be overweight due to the requirement they have an increased neck circumference of a minimum of 43 cm. Finally, all patients who went on to the treatment phase had a minimum apnea-hypopnea index (AHI) of 15 events per hour. Thus, subjects in this study appear to be very typical of the kinds of patients referred to sleep medicine centers for an OSA evaluation. The key findings of the HomePAP study demonstrated that the CPAP usage was 4.7 ± 2.1 hours in the home setting arm compared with 3.7 ± 2.4 hours in the sleep laboratory arm. Moreover, the home evaluation arm used autotitrating CPAP therapy 62.8% ± 29.2% of the nights in the study, compared with 49.4% ± 36.1% of the nights in which CPAP was used by those subjects in the sleep laboratory arm. Furthermore, functional outcomes including the Epworth Sleepiness Scale score 7 and the Functional Outcomes of Sleep Questionnaire (FOSQ)8 both improved significantly from baseline to the 3-month assessment point during the CPAP intervention within the 2 groups. There was no difference between the groups for either of these outcomes at the 3-month point. The HomePAP trial is the largest study to date examining a home-based diagnostic and treatment algorithm compared to a sleep laboratory based evaluation and treatment approach. However, there are 4 previous North American randomized trials with findings very similar to the HomePap study. Mulgrew and colleagues4 from Vancouver, BC demonstrated that home autotitrating CPAP treatment for OSA yielded clinical outcomes equivalent to those achieved in a traditional sleep laboratory CPAP titration. Patients were screened for sleep apnea symptoms and underwent a home sleep apnea test prior to randomization in their study. Berry and colleagues2 performed a randomized trial of 106 patients referred to a sleep medicine clinic at a Veterans hospital. After prescreening to select for patients with a high likelihood of sleep apnea, the investigators found that after 3 months of CPAP therapy based on either a home autotitrating CPAP trial or a laboratory-based CPAP titration, CPAP usage and functional outcomes were comparable. Similar findings were found by another group of investigators from Canada using a randomized crossover trial design.5 Finally, a VA trial of 296 patients randomized to a home diagnostic and autotitrating CPAP algorithm versus a traditional sleep laboratory approach showed that improvement in the FOSQ at 3 months was identical between the 2 groups, and that CPAP adherence was not significantly different between the home group and the sleep laboratory group, with a nonsignificant trend toward better CPAP usage in the home arm compared to the laboratory arm.3
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Home sleep testing (see Fig. 7) which traditionally measures airflow, pulse oximetry, and respiratory effort has become an acceptable technology, with clinical trials showing comparable diagnosis and treatment initiation among patients with a high likelihood of OSA [23, 24].”
From Clinician-Focused Overview and Developments in Polysomnography (2020) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Instrument to Measure Functional Status Outcomes for Disorders of Excessive Sleepiness
(1997) · Sleep · doi:10.1093/sleep/20.10.835 · Cited by 881
Rosen, C. L., Auckley, D., Benca, R., Foldvary-Schaefer, N., Iber, C., Kapur, V., Rueschman, M., Zee, P., & Redline, S. (2012) · Sleep · doi:10.5665/sleep.1870 · Cited by 367
Noninferiority of Functional Outcome in Ambulatory Management of Obstructive Sleep Apnea
Kuna, S. T., Gurubhagavatula, I., Maislin, G., Hin, S., Hartwig, K. C., McCloskey, S., Hachadoorian, R., Hurley, S., Gupta, R., Staley, B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1770oc · Cited by 228
Self-citationOutcomes of Home-Based Diagnosis and Treatment of Obstructive Sleep Apnea
Skomro, R. P., Gjevre, J., Reid, J., McNab, B., Ghosh, S., Stiles, M., Jokic, R., Ward, H., & Cotton, D. (2010) · Chest · doi:10.1378/chest.09-0577 · Cited by 125
Research works printed but not linked: 3
- Pack, 2011, Sleep medicine: strategies for change, J Clin Sleep Med, 7, 577, 10.5664/jcsm.1450 · DOI
- Mulgrew, 2007, Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study, Ann Intern Med, 146, 157, 10.7326/0003-4819-146-3-200702060-00004 · DOI · Paper page
- Johns, 1991, A new method for measuring daytime sleepiness: the Epworth sleepiness scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 · DOI · Paper page
Cited by
Clinician-Focused Overview and Developments in Polysomnography
Markun, L. C., & Sampat, A. (2020) · Current Sleep Medicine Reports · doi:10.1007/s40675-020-00197-5 · Cited by 136
Metadata
- Authors
- Atwood, C. W.
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06
- Volume
- 35
- Issue
- 6
- Pages
- 735-736
- ISSN
- 0161-8105
- 1550-9109
- Cited by
- 4
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.